Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Tackles Shortage Of Child-Friendly Devices With Pediatric Consortia Funds

This article was originally published in The Gray Sheet

Executive Summary

Seven pediatric device consortia received grants from FDA worth $18 million to promote growth in the underdeveloped pediatric device market.

You may also be interested in...



Better Reimbursement, More Incentives Needed For Peds Device Development, Stakeholders Tell FDA

At a recent pediatric medical devices workshop at US FDA headquarters, the focus turned less to regulatory burdens and more to lacking reimbursement and financial incentives as barriers to bringing child-focused products to market.

FDA Focusing On Promotion Of Pediatric Device Development In 2014

One of FDA’s New Year’s resolutions seems to be emphasizing pediatric device development, as seen in a recent final rule on capturing data on pediatric use of devices, as well as a forthcoming draft guidance on pediatric uses of medical devices.

Task Force Collaborating With FDA Issues Pediatric Heart Valve Recommendations

A new white paper lays out pre- and post-market considerations for heart valve manufacturers to earn FDA approval of a pediatric-sized version of a prosthetic heart valve that is already available in adult sizes.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032476

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel